ライフサイエンスコーパス: phacoemulsification

1 old (3-fold for M-SICS and nearly 6-fold for phacoemulsification).

2 he 40 777 private surgeries (21% M-SICS; 79% phacoemulsification).

3 Three patients had an uncomplicated phacoemulsification.

4 .6 mm (long AL) that underwent uncomplicated phacoemulsification.

5 patients with a history of CME who underwent phacoemulsification.

6 Intervention was cataract surgery by phacoemulsification.

7 and at least 5 visits in the year following phacoemulsification.

8 e use of intraocular lens (IOL) for cataract phacoemulsification.

9 cause comparable ECL to that of conventional phacoemulsification.

10 ult in similar ECL rates to that of standard phacoemulsification.

11 CT) after intraoperative complication during phacoemulsification.

12 at each clinic visit prior to and following phacoemulsification.

13 torsional (n = 26) or longitudinal (n = 26) phacoemulsification.

14 ancement in the field since the inception of phacoemulsification.

15 bility significantly improves after cataract phacoemulsification.

16 low for the enhancement of partial occlusion phacoemulsification.

17 shown to yield similar surgical outcomes as phacoemulsification.

18 influence the future quality of training in phacoemulsification.

19 ique advantages over conventional ultrasound phacoemulsification.

20 s chatter, and improved followability during phacoemulsification.

21 chlemm canal or no stent after uncomplicated phacoemulsification.

22 t patients (84 eyes) with FECD who underwent phacoemulsification.

23 ome, Italy) in patients undergoing bilateral phacoemulsification.

24 (Microsurgical Technology Inc) were used for phacoemulsification.

25 n improve surgical safety for dense cataract phacoemulsification.

26 nd long eyes using ultrasound biometry after phacoemulsification.

27 ibiotics should be considered for M-SICS and phacoemulsification.

28 ce or less ECL with FLACS than with standard phacoemulsification 1-3 months after surgery.

29 After phacoemulsification, 2 capsulotomy edge retractors attac

30 he most frequent surgical interventions were phacoemulsification (20.8%) and pars plana vitrectomy (1

31 Ruptures most frequently occurred during phacoemulsification (59.6%) and irrigation and aspiratio

32 roportion from extracapsular extraction than phacoemulsification (7.9% vs. 0.15%; P < 0.0001).

33 ter (>/=20/40) was achieved in 68% following phacoemulsification, 72% following extracapsular catarac

34 patients with POAG, combined treatment with phacoemulsification, ab-interno trabeculectomy and endos

35 cataract; each eye was treated with combined phacoemulsification, ab-interno trabeculectomy-Kahook Du

36 Phacoemulsification after GDI surgery resulted in a tran

37 tation plus phacoemulsification (n = 282) or phacoemulsification alone (n = 67) were analyzed post ho

38 tation plus phacoemulsification (n = 215) or phacoemulsification alone (n = 67) were evaluated 36, 48

39 IOP should not be expected after performing phacoemulsification alone in POAG patients.

40 ty clinic based glaucoma patients undergoing phacoemulsification alone, with at least 3 visits in the

41 bined with phacoemulsification compared with phacoemulsification alone.

42 the ECD dropped 39.6% (OD) four months after phacoemulsification and 38.1% (OS) six months postoperat

43 to those obtained with conventional coaxial phacoemulsification and established intraocular lenses.

44 Two surgical techniques were evaluated: phacoemulsification and extracapsular extraction.

45 rowth factor (VEGF) injections who underwent phacoemulsification and had a postsurgery follow-up of 6

46 ing undergone crystalline lens extraction by phacoemulsification and implantation of a CT ASPHINA 409

47 gle procedure (n = 9) or in combination with phacoemulsification and implantation of a posterior cham

48 cts were recruited and randomized to receive phacoemulsification and implantation of either the AcryS

49 Patients underwent phacoemulsification and implantation of the AcrySof SA60

50 mporal clear corneal incisions of uneventful phacoemulsification and in-the-bag intraocular lens impl

51 5 mm) undergoing uneventful crystalline lens phacoemulsification and insertion of an acrylic intraocu

52 The procedure was completed by phacoemulsification and insertion of an intraocular lens

53 To assess the long-term outcomes of phacoemulsification and intraocular lens (IOL) implantat

54 osthetic iris implantation was combined with phacoemulsification and intraocular lens (IOL) implantat

55 o had undergone XEN45 gel implantation after phacoemulsification and intraocular lens implantation ap

56 The patient underwent phacoemulsification and intraocular lens insertion using

57 Twenty-one eyes of 21 patients undergoing phacoemulsification and IOL implantation after myopic la

58 and five eyes of 81 patients, who underwent phacoemulsification and IOL implantation between January

59 omy and silicone oil tamponade combined with phacoemulsification and IOL implantation for recurrent i

60 t during the pre- and postoperative periods, phacoemulsification and IOL implantation surgery can be

61 Eyes in this series underwent phacoemulsification and IOL implantation with local anes

62 of pre-corneal tear film after simultaneous phacoemulsification and limbal relaxing incisions (LRIs)

63 ompared for all eyes and separately for both phacoemulsification and M-SICS, and for the eyes complic

64 Both phacoemulsification and manual small incision extracapsu

65 Both phacoemulsification and MSICS led to significant and sim

66 One patient underwent combined phacoemulsification and pars plana vitrectomy for retina

67 nts with diabetes, combining vitrectomy with phacoemulsification and posterior capsulectomy allows pa

68 Combining pars plana vitrectomy with phacoemulsification and posterior capsulectomy now has t

69 rocedures were performed in combination with phacoemulsification and posterior chamber intraocular le

70 dest, long-lasting decrease in IOP following phacoemulsification and posterior chamber intraocular le

71 meral (IC) moxifloxacin prophylaxis for both phacoemulsification and sutureless, manual small-incisio

72 Phacoemulsification and the contemporary implantation of

73 derwent trabeculectomy (85 eyes) or combined phacoemulsification and trabeculectomy (10 eyes) and wer

74 nt at the time of trabeculectomy or combined phacoemulsification and trabeculectomy is associated wit

75 acy and safety of trabeculectomy or combined phacoemulsification and trabeculectomy with mitomycin-C

76 In combined phacoemulsification and trabeculectomy, a one-site appro

77 d to the point that Kelman's introduction of phacoemulsification and use of intraocular lenses (IOLs)

78 Patients underwent lens phacoemulsification and were implanted bilaterally with

79 nduced clinically during cataract removal by phacoemulsification, and may be one mechanism responsibl

80 , ocular pharmacology, viscoelastic devices, phacoemulsification, and the most recent advancement, in

81 separate procedures: pars plana vitrectomy, phacoemulsification, and YAG capsulotomy into one proced

82 ive cataract surgery approaches suggests the phacoemulsification approach is preferable.

83 visualization of the anterior capsule during phacoemulsification are compared.

84 prior incisional glaucoma surgery undergoing phacoemulsification by a single surgeon between January

85 small pupils or phacodonesis) all undergoing phacoemulsification by experienced Aravind Eye Care Syst

86 lterations to normal positioning, successful phacoemulsification can be executed.

87 t participation added $105.40 to the average phacoemulsification case.

88 Prospective assessment of consecutive phacoemulsification cases (N = 500) enabled calculation

89 0, there were 887 capsule ruptures in 48 377 phacoemulsification cases (rate 1.8%).

90 udy of consecutive RP patients who underwent phacoemulsification cataract extraction and intraocular

91 tment with the femtosecond laser followed by phacoemulsification cataract extraction and IOL insertio

92 Controls underwent phacoemulsification cataract extraction plus insertion o

93 ords were reviewed of patients who underwent phacoemulsification cataract extraction with intraocular

94 r risk of developing PAU after uncomplicated phacoemulsification cataract extraction.

95 We performed phacoemulsification cataract removal on 401 patients.

96 undergoing separate first eye and second eye phacoemulsification cataract surgeries at 5 veterans aff

97 omb (B&L), Munich, Germany) and conventional phacoemulsification cataract surgery (CPCS).

98 ool for the complete four main procedures of phacoemulsification cataract surgery (rho < 0.05), indic

99 ied acute POE occurring within 6 weeks after phacoemulsification cataract surgery and the use of intr

100 Occlusion break surge during phacoemulsification cataract surgery can lead to potenti

101 l patients underwent uncomplicated first-eye phacoemulsification cataract surgery from 2000 through 2

102 us to observe a decrease in acute POE after phacoemulsification cataract surgery from 2005 to 2014.

103 Patients who underwent phacoemulsification cataract surgery from October 2016 t

104 ical data of 500 consecutive cases, prior to phacoemulsification cataract surgery performed between A

105 Phacoemulsification cataract surgery performed in MPRs o

106 perform the virtual surgery of the four main phacoemulsification cataract surgery procedures - 1) cor

107 jective of this study was to conduct virtual phacoemulsification cataract surgery to compare performa

108 icipant was required to perform the complete phacoemulsification cataract surgery using the simulator

109 consecutive small eyes undergoing uneventful phacoemulsification cataract surgery with a single highl

110 efractive results compared with conventional phacoemulsification cataract surgery, even during the in

111 dophakic macular edema occurs commonly after phacoemulsification cataract surgery, even in the absenc

112 he PPC by 2 surgeons, followed up by routine phacoemulsification cataract surgery, was undertaken.

113 ressure (IOP) 21-33 mmHg and were undergoing phacoemulsification cataract surgery.

114 se corneal ECD decreased significantly after phacoemulsification cataract surgery.

115 371 242 eyes in 3 983 525 patients underwent phacoemulsification cataract surgery.

116 or chamber following otherwise uncomplicated phacoemulsification cataract surgery.

117 cataract that underwent combined DSAEK with phacoemulsification cataract surgery.

118 occlusion break surge may increase safety of phacoemulsification cataract surgery.

119 stically equivalent to those of conventional phacoemulsification cataract surgery.

120 omparisons to outcomes found in conventional phacoemulsification cataract surgery.

121 patients undergoing clear corneal sutureless phacoemulsification cataract surgery.

122 receiving the AcrySof IOL (SN60WF) following phacoemulsification cataract surgery.

123 phakic cystoid macular edema is common after phacoemulsification cataract surgery.

124 Phacoemulsification causes a significant elevation of IO

125 groups: group A included eyes that underwent phacoemulsification combined with 25G HS-PPV (348 eyes),

126 To stratify the outcomes of phacoemulsification combined with trabectome surgery usi

127 with visually significant cataract that had phacoemulsification combined with trabectome surgery.

128 ved a Schlemm canal microstent combined with phacoemulsification compared with phacoemulsification al

129 lens (SPA-IOL) in the ciliary sulcus during phacoemulsification complicated with posterior capsule t

130 tratification seems to reduce intraoperative phacoemulsification complications in public teaching hos

131 The incidence of acute POE after phacoemulsification decreased from 0.145% to 0.053% duri

132 OP reduction was observed in eyes undergoing phacoemulsification (DeltaIOP = 2.7+/-2.9 mmHg) and MSIC

133 Training in phacoemulsification during residency is one of the most

134 Torsional phacoemulsification effectively reduces ultrasonography

135 al power becomes more critical at increasing phacoemulsification efficiencies at torsional amplitudes

136 laucoma patients with open angles undergoing phacoemulsification experienced an increase in IOP or re

137 For the 194 252 phacoemulsification eyes, the endophthalmitis rate was 0

138 After phacoemulsification, eyes were randomized 2:1 to receive

139 All patients underwent phacoemulsification followed by IOL implantation in the

140 The association of phacoemulsification for cataract with IOP reduction was

141 d to topical steroid use after uncomplicated phacoemulsification for the prevention of pseudophakic c

142 and silicone oil instillation combined with phacoemulsification for tractive retinal detachment and

143 these new glaucoma procedures combined with phacoemulsification generally include retrospective case

144 Ninety-four patients scheduled for bilateral phacoemulsification had an SE-PMMA IOL implanted in 1 ey

145 Phacoemulsification has been linked to lowered intraocul

146 y was performed alone or in combination with phacoemulsification in eyes with cataract.

147 Cataract surgery by phacoemulsification in eyes with medically controlled PO

148 s prolapse occurred, IPH was injected during phacoemulsification in group 2.

149 im of the study is to compare the outcome of phacoemulsification in patients with and without pseudoe

150 owing, and prolapse was noted during routine phacoemulsification in patients with current or previous

151 reased risk for corneal decompensation after phacoemulsification in patients with FED.

152 dissipated energy compared with longitudinal phacoemulsification in patients with FED.

153 to reduce IOP approximately 1 to 2 mmHg with phacoemulsification in patients with preoperative IOP of

154 Phacoemulsification in presence of pseudoexfoliation nec

155 s of new surgeries that can be combined with phacoemulsification in the management of cataract and gl

156 The filtering blebs after phacoemulsification in the study group were characterize

157 ct surgery, and, while not a replacement for phacoemulsification in Western countries, should be part

158 Phacoemulsification incision placement on the steep corn

159 Three MET interventions related to the phacoemulsification/intraocular lens pathway occurred in

160 Surgery included phacoemulsification, IOL (Acrysof SN60AT; Alcon) implant

161 One year after phacoemulsification, IOP decreased by a mean 1.15 +/- 3

162 In eyes with OAG, ECL after phacoemulsification is acute and stabilizes after 3 mont

163 We aim to investigate whether phacoemulsification is associated with optic disc hemorr

164 Trabeculectomy within 6 to 24 months after phacoemulsification is rare in such patients.

165 Phacoemulsification is the preferred technique for catar

166 A Signature (Abbott Medical Optics, Inc) phacoemulsification machine was used in peristaltic and

167 Cataract surgery at earlier stages by phacoemulsification may be more beneficial than undergoi

168 Although it is well recognized that phacoemulsification may result in a modest sustained red

169 atients subjected to both trabeculectomy and phacoemulsification, mean IOP was significantly higher t

170 (control) or supraciliary microstenting with phacoemulsification (microstent) groups (1:3 ratio).

171 uded ocular surgery other than clear corneal phacoemulsification, myopia >6 diopters, contact lens us

172 who underwent Micro-Stent implantation plus phacoemulsification (n = 215) or phacoemulsification alo

173 who underwent Micro-Stent implantation plus phacoemulsification (n = 282) or phacoemulsification alo

174 se posterior capsule rupture than ultrasonic phacoemulsification needles, and is more efficient than

175 Phacoemulsification of uncomplicated cataracts with intr

176 vestigated the effect of cataract surgery by phacoemulsification on intraocular pressure (IOP) in pat

177 subjects were intraoperatively randomized to phacoemulsification only (control) or supraciliary micro

178 complete cataract removal was performed with phacoemulsification only, using pulsed ultrasound energy

179 n is associated with significantly increased phacoemulsification operative times and costs during the

180 Surgery was performed using phacoemulsification or manual small-incision cataract su

181 Eyes underwent phacoemulsification or MSICS after a 1:1 randomization a

182 higher risk of complications as compared to phacoemulsification (OR = 5.95, 95% CI = 1.49-23.73, P =

183 ted with the development of lens opacity and phacoemulsification (P = .005 and .008, respectively).

184 he DEX implant greater than 4 weeks prior to phacoemulsification (P = .005).

185 neal incision (CI), 2) capsulorhexis (C), 3) phacoemulsification (P), and 4) intraocular lens implant

186 ining glaucoma surgery with minimal invasive phacoemulsification (phaco) is a considerable option to

187 To compare the efficacy of phacoemulsification (PKE) combined with nonpenetrating d

188 erformed successfully using all of the major phacoemulsification platforms.

189 stabilizes after 3 months, whereas ECL after phacoemulsification plus Micro-Stent implantation procee

190 Forty eyes underwent combined phacoemulsification, PPV, ILM peeling, and intraocular l

191 Phacoemulsification procedures conducted by 7 surgeons w

192 Recommended allocation of higher-risk phacoemulsification procedures to experienced surgeons i

193 udy included all patients undergoing routine phacoemulsification procedures with implantation of the

194 patients; follow-up, 17 months) showed that phacoemulsification reduced IOP by 13% and glaucoma medi

195 , 132 patients; follow-up, 34 months) showed phacoemulsification reduced IOP by 20% and glaucoma medi

196 , 495 patients; follow-up, 16 months) showed phacoemulsification reduced IOP by 30% and glaucoma medi

197 Phacoemulsification resulted in a small average decrease

198 Cataract surgery by phacoemulsification results in large intraocular pressur

199 ncremental improvements have made ultrasonic phacoemulsification safer to the posterior capsule and l

200 Operating room records of all phacoemulsification surgeries performed at a single acad

201 Phacoemulsification surgeries took an average of 12 minu

202 All phacoemulsification surgeries with IOL (n = 17415 eyes)

203 utive patients, aged >/=64 years, undergoing phacoemulsification surgery at Westmead Hospital were fo

204 ecutive patients aged >/=64 years undergoing phacoemulsification surgery at Westmead Hospital were re

205 not support the generalized conclusion that phacoemulsification surgery causes progression of retino

206 lic object 40 years ago and an uncomplicated phacoemulsification surgery in the same eye 2 years earl

207 Phacoemulsification surgery may aggravate the signs and

208 fect of preoperative risk stratification for phacoemulsification surgery on intraoperative complicati

209 o evaluate the visual outcomes and effect of phacoemulsification surgery on the progression of neovas

210 Phacoemulsification surgery significantly improved visio

211 ere visual impairment in older patients with phacoemulsification surgery was associated with a lower

212 eye syndrome and cataract, who had undergone phacoemulsification surgery were enrolled in this study.

213 valuate the course of dry eye syndrome after phacoemulsification surgery.

214 mild PCO occurred in one-third of eyes after phacoemulsification surgery.

215 n and customization of surgical technique in phacoemulsification surgery.

216 ld instrument that can be used in the normal phacoemulsification surgical sequence.

217 rom June 2010 through May 2015 who underwent phacoemulsification (surgical group) were matched to pat

218 for cataracts by 1 of 4 surgical approaches (phacoemulsification, sutured manual extracapsular catara

219 R) Vision System, the WhiteStar Signature(R) Phacoemulsification System, and the Centurion(R) Vision

220 break surge and vacuum rise time of current phacoemulsification systems used in cataract surgery.

221 s to determine the outcome of using combined phacoemulsification technique, ab-interno trabeculectomy

222 ation time and energy compared to the manual phacoemulsification technique.

223 Continual advances in phacoemulsification technology and adjunctive surgical d

224 surgical technique that continues to grow as phacoemulsification technology and intraocular-lens desi

225 tion techniques using microincisions and new phacoemulsification technology will enhance the safety o

226 viscoelastic materials and modifications in phacoemulsification technology.

227 e achieved with the most current advances in phacoemulsification technology.

228 ssists in understanding the advances made in phacoemulsification technology.

229 p had a significantly higher mean IOP before phacoemulsification than the BGI group (P = 0.016).

230 Lower risk of hypotony with phacoemulsification than with alternative cataract surge

231 After phacoemulsification the prevalence of some degree of PVD

232 Before phacoemulsification, the mean IOP was 14.4 +/- 4.4 mmHg

233 Phacoemulsification, the type of cataract surgery associ

234 osecond lens fragmentation method, effective phacoemulsification time (EPT), intraoperative complicat

235 nce in favor of FLACS over MCS for effective phacoemulsification time (WMD, -3.03; 95% CI, -3.80 to -

236 Effective phacoemulsification time and endothelial cell loss were

237 surgery (FLACS) has been reported to reduce phacoemulsification time and energy compared to the manu

238 ith increasing preoperative PNS-P, effective phacoemulsification time increased in both groups; howev

239 Effective phacoemulsification time was reduced 28.6% within the fe

240 Overall mean effective phacoemulsification time was significantly lower in grou

241 Effective phacoemulsification time was significantly lower in grou

242 e lens position as well as reduced effective phacoemulsification time with the use of FSL compared wi

243 ults in a significant reduction in effective phacoemulsification time, including the possibility of 0

244 allows a significant reduction in effective phacoemulsification time, which correlates positively wi

245 72.8% reduction was achieved with a 20-gauge phacoemulsification tip.

246 A total of 369 eyes were randomized after phacoemulsification to Hydrus Microstent (HMS) and 187 t

247 A total of 33 eyes (39.3%) needed EK after phacoemulsification to rehabilitate vision.

248 To examine the current status of phacoemulsification training and the factors that will i

249 The quality of phacoemulsification training in the US is currently thre

250 The impending decline in quality of phacoemulsification training in US residencies can be pr

251 Phacoemulsification typically results in small, moderate

252 a, often decreases after cataract removal by phacoemulsification ultrasound.

253 xpression was increased after treatment with phacoemulsification ultrasound.

254 Cataract surgery was performed by phacoemulsification under topical anesthesia.

255 iples guiding recent technologic upgrades in phacoemulsification units will help the surgeon to maxim

256 ere randomly assigned to 2.2 mm microcoaxial phacoemulsification using the OZil Intelligent Phaco tor

257 The average interval between GDI surgery and phacoemulsification was 9.4 +/- 6.7 months.

258 In the study group, planned phacoemulsification was converted to manual extraction i

259 Lens cube phacoemulsification was done using OZil IP at 60%, 80%,

260 Phacoemulsification was performed by 2 experienced surge

261 Phacoemulsification was performed in 5 eyes (4.9%; 95% C

262 Phacoemulsification was performed in 99.9% of cases, and

263 required long-term glaucoma medications when phacoemulsification was performed soon after medical red

264 Trabeculectomy after phacoemulsification was uncommon; the median rate report

265 POAG patients undergoing cataract surgery by phacoemulsification were retrospectively evaluated.

266 5 women, 45-66 years) who underwent cataract phacoemulsification were studied.

267 ot find an increase in ODH in the year after phacoemulsification when compared to the year prior to s

268 nt are well established tools for use during phacoemulsification when zonular instability is present.

269 Our study demonstrates that phacoemulsification whether done with a clear temporal o

270 ween the immediate 6 months before and after phacoemulsification, which was equal to 0.1667 injection

271 The combination of cataract or lens phacoemulsification with 25G HS-PPV for vitreomacular di

272 f bilateral cataract with planned removal by phacoemulsification with a clear corneal incision.

273 amination rate of 33.33% (n = 8) compared to phacoemulsification with a rate of 25% (n = 2) (RR = 1.3

274 erior group) including 50 patients underwent phacoemulsification with a superior corneal incision.

275 poral group) including 50 patients underwent phacoemulsification with a temporal corneal incision and

276 Several studies have reported that phacoemulsification with intraocular lens implantation a

277 ients with RP were categorized as having had phacoemulsification with intraocular lens implantation v

278 Phacoemulsification with intraocular lens implantation w

279 d 1510 cases (77.9%) underwent uncomplicated phacoemulsification with intraocular lens implantation w

280 All patients underwent phacoemulsification with intraocular lens implantation.

281 ucted of all cases of cataract extraction by phacoemulsification with intraocular lens insertion perf

282 EX 0.7 mg intravitreal implant and underwent phacoemulsification with intraocular lens placement.

283 The study compared eyes that underwent phacoemulsification with IOL implant at least 3 months p

284 Phacoemulsification with IOL implant, PPV with silicone

285 All eyes underwent phacoemulsification with IOL implantation and were follo

286 Concurrent phacoemulsification with lens implantation was performed

287 implantation and Group 2 patients underwent phacoemulsification with monofocal IOL implantation foll

288 luded 111 eyes of 74 patients that underwent phacoemulsification with monofocal IOL implantation.

289 l study including 12 patients, who underwent phacoemulsification with PCT and sulcus implantation of

290 ay be implanted in the ciliary sulcus during phacoemulsification with PCT rather than switching to an

291 n and preventing PCME in patients undergoing phacoemulsification with posterior chamber intraocular l

292 Phacoemulsification with posterior chamber intraocular l

293 im of the study was to analyse the effect of phacoemulsification with posterior chamber lens implanta

294 ccessful trabeculectomy with 5-Fluorouracil, phacoemulsification with posterior chamber lens implanta

295 ction in corneal endothelial cell loss after phacoemulsification with the use of viscoelastic materia

296 Group 1 patients underwent phacoemulsification with toric intraocular lens (IOL) im

297 All 5 eyes underwent phacoemulsification with use of iris retractors.

298 s that had been recorded 5 to 120 days after phacoemulsification with visual acuity 20/40 or worse an

299 manual extracapsular cataract extraction and phacoemulsification--with ECCE further separated into th

300 In the subset of eyes that underwent phacoemulsification within 4 weeks of the DEX implant (8